RE:RE:RE:RE:RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancerFor some reason mr. Qu30, keeps stating " they have the data"
Unless, he/ she is part if the trial clinics & evaluating teams, there is 100% no way to prove or unproven " they have the data".
Most importantly along that line, the trial is not run by Onc.
There are multiple recording, collecting & analysts of data required.
Seeing on the fda page the trial is over on xx date, Could / might mean many things.
For example, that date could be the close out if final treatment,
Repeating again the outcomes, specifically overall survival depends on people passing away.
Unless the trial includes murder or assisted suicide, it is impossible to determine when someone will die.
so to spout off why there are hiding results & making conclusive statements, is extreamly missleading.
One very significant point. Any " published" reults of the significance we are talking about, would be peer reviewed,
Meaning even after all the post mortality analysis, conclusions would be formalized based on the context of the trial.
THEN, a third party of qualified PHDs would review the data & conclusions.
Moving the lens further out; Does Onc mangement have a reasonable idea of the outcomes. Absolutely.
Their published on- line presentation says results will be available before the end of this year.
That is the only thing we know for sure.
saying anything different, without qualifying as " your opinion" is just not correct.
considering people's lives & the future of Oncs MBc treatment opportunity is on the line, There will be many layers if reviews etc, long before the results are made public.
Repeating my qualifications to comment. I was a patient as part of a clinical phase 2-b.
It had nothing to do with cancer.
The application process alone was 6 pages of extremely medical details.
Then, a pre- registration interview.
I did not proceed. Personl health reasons.
Had I proceeded there would have been a huge regime of medical exams. Weekly phine interviews.
on & on, all before even getting to the trial of a double blind drug treatment.
Post treatment ( when the trial time would be over...meaning no more treatments), the follow- up included 6 months of post trial medicals etc etc.
My whole point?
The bracelet trial might be indicating as over. The results?
lots of followup , before any official data can be published.
please, don't spout your opinions as apparently factual.
Other then that, we wait.